These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 7646255)

  • 1. [New therapeutic prospects in acute coronary thrombosis].
    Roux S
    Arch Mal Coeur Vaiss; 1995 Jan; 88(1):91-4. PubMed ID: 7646255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiplatelet and antithrombin therapies in the acute coronary syndromes.
    Alexander JH; Harrington RA
    Curr Opin Cardiol; 1997 Jul; 12(4):427-37. PubMed ID: 9263656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombotic therapy and the transition to the catheterization laboratory in UA/NSTEMI.
    Ferguson JJ; Wilson JM; Diez J
    Minerva Cardioangiol; 2007 Oct; 55(5):529-56. PubMed ID: 17912162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective use of platelet glycoprotein IIb/IIIa receptor blockers in the emergency department setting.
    Gibler WB; Wilcox RG; Bode C; Castaigne AD; Delooz H; Elich D; Fox KA; Kereiakes DJ; Rupprecht H; Topol EJ
    Eur J Emerg Med; 1998 Dec; 5(4):391-402. PubMed ID: 9919443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The scientific basis for combined platelet and thrombin-directed pharmacotherapy in acute coronary syndromes.
    Becker RC
    J Invasive Cardiol; 2000 Dec; 12 Suppl E():E19-24;discussion E25-8. PubMed ID: 11156725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycoprotein IIb/IIIa antagonists: do they have a role in the management of unstable angina?
    Redwood S; Marber M; Jackson G
    Int J Clin Pract; 1999 Dec; 53(8):618-22. PubMed ID: 10692757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harnessing the platelet.
    Futterman LG; Lemberg L
    Am J Crit Care; 1997 Sep; 6(5):406-14. PubMed ID: 9283679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous integrin alphavbeta3 and glycoprotein IIb/IIIa inhibition causes reduction in infarct size in a model of acute coronary thrombosis and primary angioplasty.
    Sakuma T; Sari I; Goodman CN; Lindner JR; Klibanov AL; Kaul S
    Cardiovasc Res; 2005 Jun; 66(3):552-61. PubMed ID: 15914120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wall passivation for unstable angina.
    Lettino M; Dailey-Sterling F; Badimon L; Chesebro JH; Badimon JJ
    Semin Interv Cardiol; 1996 Mar; 1(1):60-6. PubMed ID: 9552495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current approach in antithrombotic treatment during coronary interventions: specific thrombocyte aggregation inhibitors and direct thrombin antagonists in high-risk patients].
    Meyer BJ
    Schweiz Med Wochenschr; 1996 Nov; 126(46):1961-9. PubMed ID: 8984604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycoprotein IIb/IIIa inhibitors in unstable angina.
    Theroux P
    Curr Opin Cardiol; 1997 Sep; 12(5):447-52. PubMed ID: 9352171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antiplatelet therapy during coronary endoprosthesis placement].
    Barragan P; Pietri P; Villain P; Silvestri M; Roquebert PO
    Arch Mal Coeur Vaiss; 1996 Nov; 89(11 Suppl):1515-20. PubMed ID: 9092412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary atherothrombotic disease: progress in antiplatelet therapy.
    Badimon L; Vilahur G
    Rev Esp Cardiol; 2008 May; 61(5):501-13. PubMed ID: 18462654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
    Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of cardiovascular events after acute coronary syndrome.
    Wallentin L
    Semin Vasc Med; 2005 Aug; 5(3):293-300. PubMed ID: 16123917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet aggregation inhibitors in prevention and treatment of coronary thrombosis.
    Gomes ME; Verheugt FW
    Neth J Med; 2003 Jun; 61(6):185-92. PubMed ID: 12948162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacologic therapy of acute coronary syndromes].
    Holm F; Aschermann M
    Cas Lek Cesk; 2003 Aug; 142(8):456-9. PubMed ID: 14626558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigational antiplatelet drugs for the treatment and prevention of coronary artery disease.
    Zeidner JF; Frishman WH; Lerner RG
    Cardiol Rev; 2008; 16(5):250-9. PubMed ID: 18708826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, procedural, and pharmacologic correlates of acute and subacute stent thrombosis: results of a multicenter case-control study with 145 thrombosis events.
    Rinaldi MJ; Kirtane AJ; Piana RN; Caputo RP; Gordon PC; Lopez JJ; Dauerman HL; Ryan TJ; Kiernan FJ; Cutlip DE; Ho KK; Gibson CM; Murphy SA; Cohen DJ
    Am Heart J; 2008 Apr; 155(4):654-60. PubMed ID: 18371472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clopidogrel: an updated and comprehensive review.
    Fox KA; Chelliah R
    Expert Opin Drug Metab Toxicol; 2007 Aug; 3(4):621-31. PubMed ID: 17696811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.